Hetero Biopharma

Hetero Biopharma, part of the Hetero Group, is a leader in the biologics vertical, with proven capabilities in the development, manufacturing, and marketing of APIs, ARVs, and finished formulations. Hetero strategically operates 36 state-of-the-art manufacturing facilities worldwide. The majority of their facilities have successfully passed inspections and gained approvals from regulatory bodies such as the U.S. FDA, EU, TGA-Australia, and MCC-South Africa. The company’s portfolio includes over 300 products covering disease areas such as HIV/AIDS, oncology, cardiovascular, neurology, hepatitis, nephrology, urology, diabetes, ophthalmology, hepatology, and immunology, focusing on providing affordable medicines to patients globally.